LOS DERIVADOS DEL BIS-P-HIDROXIFENIL METANO COMO LAXANTES
Abstract
Se revisa el estado actual de conocimientos físicos, químicos, farmacológicos y terapéuticos de los derivados del bis-p-hidroxifenilmetano, de manera especial los de pro piedades laxantes y de entre ellos del derivado diacetoxipiridil (“Bisacodyl” o “Dulco-lax”.)
Downloads
References
A. V. BAETER y L. B. BURKART. -Liebig Ann. Chem. 202, 126, 1880.
O. E. SCHULTZ y L. GELLER.-Archiv der Pharm. 287, 582, 1954.
O. E. SCHULTZ y L. GELLER.-Archiv der Pharm. 228, 234, 1955.
P. Br. 730.243 de 18 de mayo 1955, C. A. 50, 6515, 1956.
L. SCHMIDT.-Arzneimittel Forschung 3, 19, 1953.
L. SCHMIDT y E. SEEGER.-Arzneimittel Forschung 6, 22, 1956.
H. BARTH.-Deutsch. Med. J. 4, 415. 1953.
NAMYN-SCHMIEDLIBERGS.-Arch. exp. Pathol. Pharmakol. 226, 207, 1955 de Ch 9455, 1957.
A. MARINO.-Clin terap. 10, 642, 1956 de C. A. 51, 9941 d , 1957.
A. GUARNÉR.-An. Hosp. Santa Cruz y S. Pablo XVIII (1) 61, 1958.
«Merek Index 1960», pág. 152.
J. M. SUÑÉ y C. FAULÍ -An. R. Acad. Farm. (en prensa).
B. GARIN.-«Fármacos, Enciclopedia de medicamentos y especialidades, S. Sebastián, 1958, pág. 2.683.
CH. O. WILSON Y T. E. JONES-«American Drug Index 1959, J. B. Lippincott Co., Philadelphia a. Montreal, pág. 231.
"Rote Liste 1961, Editio Cantor, Aulendorf/Württ, pág. 290.
E. AYE y F. DIEPENBROCK.-«Aarzneispezialitaten nach Indikationzgebietern, Wisenschaftliche Verlagsgessellschaft m. b. H., Stuttgart 1959, pág. 351.
E. BERNOUILLI y H. LEHMANN.-«Uebersieht der gebräuchlichen und neueren Arzneimittel, Benno Schwabe Co. Verlag, Basel/Stuttgart 1959, pág. 164.
L. VIDAL.-«Dictionnaire de Spécialités Pharmaceutiques», Office de vulgarisation pharmaceutique, Paris 1960, pág. 517.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).